38 results
SC 13E3/A
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Going private transaction (amended)
9:16am
part of the fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify
SC 14D9
STSA
Satsuma Pharmaceuticals Inc
5 May 23
Tender offer solicitation
8:17am
any net cash or stock received from the foregoing shares underlying such option, which will offset advisory fees owed by RA Capital Fund to RA
SC TO-C
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
Information about tender offer
6:08am
as it relates solely to preliminary communications made before the commencement of the tender offer
Check box if any part of the fee is offset
8-K
EX-99.1
oszmnteow1ene zb0l
3 Nov 22
Satsuma Pharmaceuticals Reports Third Quarter 2022 Financial Results and Recent Business Highlights
4:00pm
8-K
EX-99.1
69ohr2x750la
10 May 22
Satsuma Pharmaceuticals Reports First Quarter 2022 Financial Results
4:02pm
8-K
EX-99.1
tgu8u88tps9upu gz3r0
15 Mar 22
Satsuma Pharmaceuticals Reports 2021 Full Year and Fourth Quarter Financial Results and Business Highlights
4:40pm
8-K
EX-99.1
lgesz7iabtwo8u jdaz
9 Nov 21
Satsuma Pharmaceuticals Reports Third Quarter 2021 Financial Results
5:00pm
8-K
EX-99.1
p5wbo8pdgpg3a qb
10 Aug 21
Satsuma Pharmaceuticals Reports Second Quarter 2021 Financial Results
4:01pm
8-K
EX-99.1
dhau890gi9shx
11 May 21
Satsuma Pharmaceuticals Reports First Quarter 2021 Financial Results
4:05pm
DEFA14A
ampnbn
19 Apr 21
Additional proxy soliciting materials
4:56pm